Mark Kotter
AeroLeads people directory · profile

Mark Kotter Email & Phone Number

PRA (Research Professor) at University of Cambridge
Location: Greater Cambridge Area, United Kingdom, United Kingdom 13 work roles 3 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
PRA (Research Professor)
Location
Greater Cambridge Area, United Kingdom, United Kingdom
Company size

Who is Mark Kotter? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Mark Kotter is listed as PRA (Research Professor) at University of Cambridge, a company with 67 employees, based in Greater Cambridge Area, United Kingdom, United Kingdom. AeroLeads shows a matched LinkedIn profile for Mark Kotter.

Mark Kotter previously worked as Founder and CEO at Bit Bio and NIHR Clinician Scientist at University Of Cambridge. Mark Kotter holds Doctor Of Philosophy (Phd) from University Of Cambridge.

Company email context

Email format at University of Cambridge

This section adds company-level context without repeating Mark Kotter's masked contact details.

University of Cambridge

Review company-level records connected to Mark Kotter before choosing the right outreach path.

Profile bio

About Mark Kotter

I am a neurosurgeon, stem cell biologist, and entrepreneur. I serve as CEO and Founder of bit.bio, Co-Founder of Meatable, Scientific Founder and Chairman of rejuvenation start-up clock.bio and Co-Founder and trustee of Myelopathy.org, the first charity dedicated to a common yet often overseen condition causing a 'slow motion spinal cord injury.At bit.bio, we are at the forefront of synthetic biology, coding human cells for novel cures. We are empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells and provide human cells for drug discovery, research, and cell therapies. We apply a patented safe harbour gene-targeting approach, opti-ox™, to inducibly express transcription factor combinations that reprogram human induced pluripotent stem cells (iPSCs) into highly defined and mature human cell types. Our cell identity coding platform has the ability to create any human cell type and manufacture it at scale with unparalleled precision and consistency.I believe that biology is our software and cells are our cures. Every cell type we create has the potential to give rise to multiple next-generation therapies. My commitment lies in advancing the field of biology through engineering and technology to tackle crucial human medical challenges, such as cancer, neurodegeneration, rare diseases, and the consequences of aging-related health issues.

Current workplace

Mark Kotter's current company

Company context helps verify the profile and gives searchers a useful next step.

University of Cambridge
University Of Cambridge
PRA (Research Professor)
cambridge, cambridgeshire, united kingdom
Website
Employees
67
AeroLeads page
13 roles · 20 years

Mark Kotter work experience

A career timeline built from the work history available for this profile.

Founder And Ceo

Current

Cambridge

bit.bio is a synthetic biology company focused on human cells that is advancing medicine (UN SDG9) and enabling curative treatments (UN SDG3). The company does this by industrialising the manufacture of human cells and making them more accessible. The company was spun out of the University of Cambridge in 2016 and has since raised approximately $200m from.

Nov 2016 - Present

Nihr Clinician Scientist

Principal Investigator leading a translational research group focussing on stem cells, human disease modelling, and experimental medicine trials for neurological diseases.

Mar 2016 - Apr 2024

Clinical Lecturer In Neurosurgery

My group is interested in the biology of adult CNS stem and precursor cells. We use cellular re-programming techniques to gain insight in the transcriptional and epigenetic events that determine cellular identity. In particular, we are interested in understanding genetic and epigenetic mechanisms that define the cellular states of OPCs, neural stem cells.

Jan 2009 - Mar 2016

Co-Founder

Current

Netherlands

Meatable is an innovative food technology company, aiming to deliver, at scale, cultivated meat that looks like, tastes like, and has the nutritional profile of traditional meat because it is real meat. Meatable’s goal is to satisfy the world’s appetite for meat without harming people, animals or the planet. Its process centers around the use of.

May 2018 - Present

Co-Founder

Current

Cambridge, England, United Kingdom

clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells. clock.bio’s mission is to extend healthspan by 20 years based on biomarkers of aging in a Phase 3 trial by the end of this decade.

Jan 2023 - Present

Member Of The Steering Committe, Spinal Cord Injury Forum

Current
2018 - Present ~8 yrs 4 mos

Founder

Current
Myelopathy.Org

Cambridge, United Kingdom

www.myelopathy.org

Jan 2016 - Present

Research Group Leader

Max Planck Institute For Experimental Medicine
2008 - 2009 ~1 yr
Team & coworkers

Colleagues at University of Cambridge

Other employees you can reach at bit.bio. View company contacts for 67 employees →

3 education records

Mark Kotter education

FAQ

Frequently asked questions about Mark Kotter

Quick answers generated from the profile data available on this page.

What company does Mark Kotter work for?

Mark Kotter works for University of Cambridge.

What is Mark Kotter's role at University of Cambridge?

Mark Kotter is listed as PRA (Research Professor) at University of Cambridge.

Where is Mark Kotter based?

Mark Kotter is based in Greater Cambridge Area, United Kingdom, United Kingdom while working with University of Cambridge.

What companies has Mark Kotter worked for?

Mark Kotter has worked for University Of Cambridge, Bit Bio, Meatable, Clock.Bio, and Nihr Brain Injury Medtech Co-Operative.

Who are Mark Kotter's colleagues at University of Cambridge?

Mark Kotter's colleagues at University of Cambridge include Kaiser Karim, Petra Parać, Aurora V., Hannah Garnett, and Ankitha Johnas.

How can I contact Mark Kotter?

You can use AeroLeads to view verified contact signals for Mark Kotter at University of Cambridge, including work email, phone, and LinkedIn data when available.

What schools did Mark Kotter attend?

Mark Kotter holds Doctor Of Philosophy (Phd) from University Of Cambridge.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Mark Kotter you were looking for.

View similar profiles